INTERNATIONAL PATENT: 4TEEN4 PHARMACEUTICALS GMBH FILES APPLICATION FOR "DPP3 BINDERS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION"

GENEVA, March 9 -- 4TEEN4 PHARMACEUTICALS GMBH (NeuendorfstraBe 15A16761 Hennigsdorf) filed a patent application (PCT/EP2025/074230) for "DPP3 BINDERS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION" on Aug 26, 2025. With publication no. WO/2026/046968, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERGMANN, Andreas (Am Rosenanger 7813465 Berlin)

Abstract: Subject of the invention are DPP3 binders for use in therapy or prevention of endothelial dysfunction in a patient wherein the level of Pro-Adrenomedullin or a fragment...